SHANTEL VALENTIN: Open Payments
NPI 1073274874 · ELMSFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,473 in 17 payments from 9 companies in 2025. Trend: 2023 $100 · 2024 $73 · 2025 $1,473
Food & beverage: $1,473
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 6 | $661 |
| Lilly USA, LLC | 2 | $150 |
| Genentech USA, Inc. | 1 | $150 |
| Janssen Biotech, Inc. | 2 | $147 |
| ARGENX US, INC. | 1 | $125 |
| Eisai Inc. | 1 | $125 |
| Alexion Pharmaceuticals, Inc. | 2 | $69 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: Gamunex-C, Xembify, Ocrevus, VYVGART, Leqembi, OMVOH, ULTOMIRIS, KISUNLA.
Industry payments across NY — which companies pay providers there.
